Given the above observations, MAML1 behaves as a potent transcriptional coactivator of GLI1 to strongly empower the expression of specific SHh target genes, suggesting that MAML1 may be considered as a novel therapeutic target for developing innovative cancer treatment to contrast cancer growth and proliferation (Quaranta et al., 2017). The gene discussed is MAML1; the disease is cancer.